Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia

Autoimmune hemolytic anemia (AIHA) therapy may be associated with severe complications such as diabetes, hypertension, obesity, osteoporosis, peptic ulcers, infection, and some other diseases. To reduce those effects, we used low-dose rituximab, bortezomib and dexamethasone (LowR-BD regimen) to trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Mingkang, Zhang, Jingjing, Li, Ying, Lv, Linlin, Jia, Lu, Yang, Chunyan, Huang, Yu, Liu, Haihui, Wang, Jian, Chen, Mingtai, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797600/
https://www.ncbi.nlm.nih.gov/pubmed/35089216
http://dx.doi.org/10.1097/MD.0000000000028679

Ejemplares similares

Ejemplares similares